Select Committee · Health and Social Care Committee

Availability of Orkambi on the NHS inquiry

Status: Closed Opened: 30 Nov 2018 Closed: 30 Nov 2018

The Committee’s inquiry concentrated on the provision and pricing of Orkambi, and other drugs developed by Vertex Pharmaceuticals for the treatment of cystic fibrosis. The Committee considered the positions taken in the negotiations between Vertex and NHS England, and NICE’s assessment of the cost-effectiveness of these drugs.

Oral evidence sessions

1 session
Date Witnesses
7 Mar 2019 Session View ↗

Correspondence

22 letters
DateDirectionTitle
24 Oct 2019 From cttee Letter to the Chair of the Committee from NHS England, regarding cystic fibrosi…
24 Oct 2019 To cttee Letter from Vertex, regarding the availability of Orkambi on the NHS, 24 Octobe…
30 May 2019 To cttee Letter from NICE regarding update on the progress of negotiations on the availa…
23 May 2019 To cttee Letter from NHS England regarding update on the progress of negotiations on the…
23 May 2019 To cttee Letter from Vertex Pharmaceuticals regarding update on the progress of negotiat…
13 Mar 2019 From cttee Letter to the Rt Hon Matt Hancock MP, Secretary of State for Health and Social …
30 Jan 2019 Document from NHS England, 16 January 2018
30 Jan 2019 Document from NICE, 15 January 2019
30 Jan 2019 To cttee Letter from Vertex to NHSE dated, 16 January 2019
30 Jan 2019 To cttee Letter from Vertex to NICE dated, 16 January 2019
30 Jan 2019 To cttee Letter from NICE to Vertex dated, 13 December 2018
30 Jan 2019 Document from NHS England, 16 January 2018
30 Jan 2019 Documents from Vertex Pharmaceutical (Europe) Ltd, 16 January 2019
20 Dec 2018 Submission from European Association of Bioindustries
20 Dec 2018 Submission from UK BioIndustry Association
20 Dec 2018 Documents from Vertex Pharmaceuticals, 30 November 2018
20 Dec 2018 Submission from the parents of a young child with Cystic Fibrosis
20 Dec 2018 Documents from the National Institute for Health and Care Excellence (NICE), 29…
20 Dec 2018 Documents from NHS England, 28 November 2018
20 Dec 2018 To cttee Letter from the Chair requesting documents from NHS England, the National Inst…